Walleye Trading LLC - REPLIGEN CORP ownership

REPLIGEN CORP's ticker is RGEN and the CUSIP is 759916109. A total of 434 filers reported holding REPLIGEN CORP in Q3 2023. The put-call ratio across all filers is 0.90 and the average weighting 0.1%.

Quarter-by-quarter ownership
Walleye Trading LLC ownership history of REPLIGEN CORP
ValueSharesWeighting
Q3 2023$9,777,366
+103.7%
61,489
+81.3%
0.03%
+85.7%
Q2 2023$4,798,748
+738.3%
33,923
+897.7%
0.01%
+1300.0%
Q1 2023$572,424
+111.3%
3,400
+112.5%
0.00%0.0%
Q4 2022$270,896
-74.3%
1,600
-71.4%
0.00%
-66.7%
Q1 2022$1,053,000
-52.7%
5,600
-33.3%
0.00%
-57.1%
Q4 2021$2,225,000
-61.1%
8,400
-57.6%
0.01%
-65.0%
Q3 2021$5,722,000
+145.6%
19,800
+69.6%
0.02%
+122.2%
Q2 2021$2,330,000
+9.0%
11,672
+6.1%
0.01%
-10.0%
Q1 2021$2,138,000
+330.2%
11,000
+323.4%
0.01%
+233.3%
Q4 2020$497,000
+132.2%
2,598
+79.5%
0.00%
+200.0%
Q3 2020$214,000
-40.4%
1,447
-50.1%
0.00%
-66.7%
Q2 2020$359,000
-75.6%
2,900
-81.8%
0.00%
-70.0%
Q4 2019$1,470,000
+199.4%
15,894
+148.3%
0.01%
+150.0%
Q3 2019$491,000
-90.1%
6,400
-88.9%
0.00%
-90.7%
Q2 2019$4,976,000
+858.8%
57,900
+559.6%
0.04%
+975.0%
Q1 2019$519,000
-87.1%
8,778
-88.5%
0.00%
-86.7%
Q4 2018$4,037,000
+224.0%
76,550
+240.8%
0.03%
+328.6%
Q3 2018$1,246,000
+13.7%
22,464
-3.6%
0.01%
+16.7%
Q2 2018$1,096,000
-40.5%
23,300
-54.2%
0.01%
-45.5%
Q1 2018$1,841,000
+464.7%
50,900
+465.6%
0.01%
+450.0%
Q4 2017$326,000
+32500.0%
9,000
+30934.5%
0.00%
Q4 2015$1,000
-97.8%
29
-98.2%
0.00%
Q3 2015$45,000
+1025.0%
1,600
+1500.0%
0.00%
Q2 2015$4,0001000.00%
Other shareholders
REPLIGEN CORP shareholders Q3 2023
NameSharesValueWeighting ↓
12 West Capital Management LP 1,021,641$295,244,00013.47%
Ally Bridge Group (NY) LLC 70,000$20,229,0005.95%
Miura Global Management 85,000$24,564,0003.81%
Conestoga Capital Advisors, LLC 871,390$251,823,0003.48%
Ranger Investment Management 187,723$54,250,0002.90%
AWM Investment Company, Inc. 100,000$28,899,0002.84%
Brown Capital Management 1,017,477$294,041,0002.41%
Stephens Investment Management Group LLC 558,287$161,339,0002.19%
Yorktown Management & Research Co Inc 10,050$2,904,0002.18%
SV Health Investors, LLC 14,541$4,203,0002.06%
View complete list of REPLIGEN CORP shareholders